July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Risk factors associated with progression to referable diabetic retinopathy(RDR): A Type 2 Diabetes Mellitus(T2D) cohort study in Ireland.
Author Affiliations & Notes
  • JOHN SMITH
    WELLCOME-WOLFSON CENTRE FOR EXPERIMENTAL MEDICINE, QUEENS UNIVERSITY BELFAST, BELFAST, United Kingdom
  • Noemi Lois
    WELLCOME-WOLFSON CENTRE FOR EXPERIMENTAL MEDICINE, QUEENS UNIVERSITY BELFAST, BELFAST, United Kingdom
  • Peter Henry Scanlon
    OPHTHALMOLOGY, UNIVERSITY OF GLOUCESTER, GLOUCESTER, United Kingdom
  • DAVID WRIGHT
    CENTRE FOR PUBLIC HEALTH, QUEENS UNIVERSITY BELFAST, BELFAST, United Kingdom
  • Footnotes
    Commercial Relationships   JOHN SMITH, None; Noemi Lois, None; Peter Scanlon, None; DAVID WRIGHT, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1084. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JOHN SMITH, Noemi Lois, Peter Henry Scanlon, DAVID WRIGHT; Risk factors associated with progression to referable diabetic retinopathy(RDR): A Type 2 Diabetes Mellitus(T2D) cohort study in Ireland.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1084.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Currently it remains unclear whether the addition of other potential risk indicators [e.g. glycated hemoglobin (HbA1c) level, systolic/diastolic blood pressure, serum lipids (LDL, HDL, triglycerides) levels and body mass index (BMI)] enhance the accuracy of the prediction of development of RDR based solely on outcome of previous digital image based ophthalmic evaluation. To determine factors associated with progression to RDR from a regional population-based screening programme in people with T2D in Ireland.

Methods : A dynamic cohort study of 2770 people with T2D identified during a diabetes programme operated at 20 general practices in four counties in Ireland. Patients were recruited between April 2005 and July 2013. Systemic parameters [systolic and diastolic blood pressure; glycosylated hemoglobin (HbA1c); serum lipid levels; body mass index (BMI)] and diabetic retinopathy grading were serially evaluated at four-month and yearly intervals, respectively. Associations between risk factors
i a) baseline ophthalmic evaluation outcome i b) baseline measurement of systemic variable parameter
ii) most recently recorded value of systemic parameter
iii) weighted mean of the rate of change in value between each pair of consecutive systemic parameter evaluations
and hazard of development of RDR were estimated using proportional hazard models.

Results : There was a four-fold increased risk of progression to RDR when the initial retinopathy evaluation outcome showed minimal retinopathy when compared with no retinopathy (hazard ratio 4.02, [C.I. 2.80, 5.78] p=<0.001). Higher HbA1c at baseline and recent increase in HbA1c increased the risk of RDR [hazard ratio 1.29 (C.I. 1.13, 1.48) p=<0.001 and hazard ratio 1.22, (C.I. 1.11, 1.34) p=<0.001; respectively]. Higher recent systolic BP was associated with increased referral risk (H.R.1.29 [C.I. 1.15, 1.45] p=<0.001).A recent increase in triglycerides level was associated also with an increased risk of RDR development (H.R. 1.10 [C.I. 1.03, 1.18] p=0.004).

Conclusions : Presence of overt retinopathy was strongly associated with risk of RDR. Modest associations between elevation of HbA1c,systolic BP and triglyceride levels were also detected.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Cox Proportional Hazard of development of referable diabetic retinopathy (RDR) related to outcomes of baseline ophthalmic evaluation and dynamic systemic variable evaluation (n=1775).

Cox Proportional Hazard of development of referable diabetic retinopathy (RDR) related to outcomes of baseline ophthalmic evaluation and dynamic systemic variable evaluation (n=1775).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×